US Patent Issued to BioAtla on June 9 for "Anti-CTLA4 antibodies, antibody fragments, their immunoconjugates and uses thereof" (California, Wyoming Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,793, issued on June 9, was assigned to BioAtla Inc. (San Diego).

"Anti-CTLA4 antibodies, antibody fragments, their immunoconjugates and uses thereof" was invented by Jay M. Short (Jackson, Wyo.), Gerhard Frey (San Diego) and Hwai Wen Chang (San Marcos, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A polypeptide having a heavy chain variable region and/or light chain variable region that specifically binds to CTLA4 protein as well as antibodies and antibody fragments containing the heavy chain variable region and/or the light chain variable region that bind to CTLA4 protein. Pharmaceutical compositions and kits comprising the polypeptide or an...